Huntington's disease leads to decrease of GABA-A tonic subunits in the D2 neostriatal pathway and their...

Area of Science:

• Neuroscience
• Molecular Biology
• Neurodegenerative Diseases

Background:

• Gamma-aminobutyric acid (GABA) is a key inhibitory neurotransmitter.
• GABA-A receptors, composed of various subunits, mediate phasic and tonic inhibition.
• Tonic GABA-A receptors are typically extrasynaptic, regulating neuronal excitability.

Purpose of the Study:

• To investigate the ultrastructural localization of specific GABA-A tonic receptor subunits in the D2 medium-size spiny neurons of the neostriatum.
• To examine these changes in the YAC128 murine model of Huntington's disease (HD) at different disease stages.
• To determine if GABA-A tonic receptor localization is altered in early HD progression.

Main Methods:

• Immunoelectron microscopy was used to determine the ultrastructural localization of GABA-A-α5, -β3, -δ, -ρ2, and -ρ3 subunits.
• Electrophysiological recordings were performed on neostriatal slices from YAC128 mice and wild-type controls.
• YAC128 mice were studied at 6 and 12 months of age to assess disease progression.

Main Results:

• All five investigated GABA-A tonic receptor subunits were mislocalized from peri/extrasynaptic sites into synaptic clefts in YAC128 mice.
• This mislocalization was observed as early as 6 months of age, indicating an early pathological change.
• Synaptic localization correlated with increased sensitivity to GABA-A receptor antagonists.
• The association of tonic receptors with D2 neurons diminished significantly by 12 months of age.

Conclusions:

• Huntington's disease is associated with early-onset mislocalization of GABA-A tonic receptors in the neostriatum.
• This aberrant synaptic localization alters receptor function and may contribute to the pathophysiology of HD.
• The findings highlight a novel cellular mechanism potentially underlying D2 neuron dysfunction in Huntington's disease.